Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Supriya Lifescience Yönetim

Yönetim kriter kontrolleri 2/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	no data
CEO sahipliği	n/a
Yönetim ortalama görev süresi	4.1yrs
Yönetim Kurulu ortalama görev süresi	5.3yrs

Son yönetim güncellemeleri

Recent updates

CEO

Supriya Lifescience CEO'su yok ya da onlar hakkında elimizde veri yok.

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Satish Wagh	Founder	16.6yrs	₹11.65m	67.64% ₹ 30.2b
Smita Wagh	Whole-time Director	16.6yrs	₹1.75m	0.40% ₹ 178.6m
Saloni Wagh	Managing Director	5.3yrs	₹1.81m	0.13% ₹ 56.8m
Shivani Wagh	Joint Managing Director	5.3yrs	₹1.81m	0.13% ₹ 56.8m
Balasaheb Sawant	Whole Time Director	1.4yrs	₹632.00k	Veri yok
Krishna Raghunathan	Chief Financial Officer	1.8yrs	₹3.34m	Veri yok
Shireesh Ambhaikar	Technical Head	2yrs	₹892.00k	Veri yok
Sushanta Kumar Mishra	Chief Scientific Officer	3.1yrs	Veri yok	Veri yok
Shweta Singh	Compliance Officer & Company Secretary	5.2yrs	₹940.00k	Veri yok
Prashant Zate	Head of Corporate Quality Assurance & Regulatory Affairs	16.9yrs	Veri yok	Veri yok
Shekhar Bhirud	President - Business Development	1.4yrs	Veri yok	Veri yok

4.1yrs

Ortalama Görev Süresi

60yo

Ortalama Yaş

Deneyimli Yönetim: 543434 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 4.1 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Satish Wagh	Founder	16.6yrs	₹11.65m	67.64% ₹ 30.2b
Smita Wagh	Whole-time Director	16.6yrs	₹1.75m	0.40% ₹ 178.6m
Saloni Wagh	Managing Director	5.3yrs	₹1.81m	0.13% ₹ 56.8m
Shivani Wagh	Joint Managing Director	5.3yrs	₹1.81m	0.13% ₹ 56.8m
Balasaheb Sawant	Whole Time Director	1.4yrs	₹632.00k	Veri yok
Neelam Arora	Independent Director	3.6yrs	₹12.00k	Veri yok
Dileep Jain	Independent Director	3.6yrs	₹16.00k	Veri yok
Dinesh Modi	Independent Director	3.6yrs	₹18.00k	Veri yok
Kedar Karmarkar	Independent Director	9.7yrs	₹17.00k	Veri yok
Bhairav Chokshi	Independent Director	9.7yrs	₹18.00k	Veri yok

5.3yrs

Ortalama Görev Süresi

62.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 543434 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 5.3 yıldır).

Supriya Lifescience Yönetim

Yönetim kriter kontrolleri 2/4

Anahtar bilgiler

Son yönetim güncellemeleri

Supriya Lifescience Limited, Annual General Meeting, Sep 27, 2024

Insufficient new directors

Supriya Lifescience Limited, Annual General Meeting, Sep 29, 2023

Supriya Lifescience Limited, Annual General Meeting, Sep 29, 2023

Founder recently bought ₹2.5m worth of stock

Founder recently bought ₹2.5m worth of stock

Recent updates

Dividend increased to ₹0.80

Supriya Lifescience Limited, Annual General Meeting, Sep 27, 2024

First quarter 2025 earnings released: EPS: ₹5.54 (vs ₹3.54 in 1Q 2024)

Supriya Lifescience Limited to Report Q1, 2025 Results on Aug 10, 2024

Supriya Lifescience Limited Recommends Final Dividend for the Fiscal 2024

Full year 2024 earnings released: EPS: ₹14.80 (vs ₹11.17 in FY 2023)

Supriya Lifescience Limited to Report Q4, 2024 Results on May 28, 2024

Investor sentiment improves as stock rises 17%

Insufficient new directors

Price target increased by 47% to ₹401

Investor sentiment improves as stock rises 16%

Third quarter 2024 earnings released: EPS: ₹3.70 (vs ₹1.18 in 3Q 2023)

Supriya Lifescience Limited to Report Q3, 2024 Results on Feb 07, 2024

Now 21% undervalued

Now 20% undervalued

Investor sentiment improves as stock rises 16%

Investor sentiment improves as stock rises 16%

Second quarter 2024 earnings released: EPS: ₹2.97 (vs ₹2.10 in 2Q 2023)

Supriya Lifescience Limited to Report Q2, 2024 Results on Nov 07, 2023

Supriya Lifescience Limited, Annual General Meeting, Sep 29, 2023

Supriya Lifescience Limited, Annual General Meeting, Sep 29, 2023

First quarter 2024 earnings released: EPS: ₹3.54 (vs ₹3.14 in 1Q 2023)

Supriya Lifescience Limited to Report Q1, 2024 Results on Aug 03, 2023

Supriya Lifescience Limited Recommends Final Dividend for the Year Ended March 31, 2023

Supriya Lifescience Limited to Report Q4, 2023 Results on May 26, 2023

Founder recently bought ₹2.5m worth of stock

Founder recently bought ₹2.5m worth of stock

Third quarter 2023 earnings released: EPS: ₹1.18 (vs ₹4.93 in 3Q 2022)

Supriya Lifescience Limited to Report Q3, 2023 Results on Feb 14, 2023

Supriya Lifescience Limited Resignation of Balasaheb Sawant as Whole Time Director

Supriya Lifescience Limited to Report Q2, 2023 Results on Nov 10, 2022

Supriya Lifescience Limited Announces Executive Changes

Supriya Lifescience Limited, Annual General Meeting, Sep 16, 2022

First quarter 2023 earnings released: EPS: ₹3.14 (vs ₹6.51 in 1Q 2022)

Supriya Lifescience Limited to Report Q1, 2023 Results on Aug 12, 2022

Full year 2022 earnings released: EPS: ₹18.86 (vs ₹16.92 in FY 2021)

Supriya Lifescience Limited Recommends the Final Dividend

Investor sentiment improved over the past week

Supriya Lifescience Limited to Report Q4, 2022 Results on May 20, 2022

High number of new directors

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

High number of new directors

CEO

Liderlik Ekibi

Ortalama Görev Süresi

Ortalama Yaş

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş